Recently, TG2 has been reported to participate in the formation of filamentous CXCL12–keratin-19 covalent heterodimers that coat tumor cells and mediate T cell exclusion in breast cancer tissues, which has been mentioned above in 5.2. This evidence concerns the gene KRT19 and breast carcinoma.